Search Tag: Hologic
2016 01 Aug
Hologic Applauds NCCN for Recognizing the Comprehensive Body of Literature Supporting the Use of 3D MAMMOGRAPHY™ Exams for Breast Cancer Screening Hologic Inc. has announced that new guidelines published by the National Comprehensive Cancer Network (NCCN) recommend that physicians consider breast tomosynthesis exams as an option for their patients'...Read more
2016 28 Jul
-- GAAP Diluted EPS of $0.30 Increases 200%, Non-GAAP Diluted EPS of $0.51 Increases 18.6% -- -- Revenue of $717.4 Million Grows 3.4%, 3.6% in Constant Currency -- -- Company Raises Full-Year, Non-GAAP Diluted EPS Guidance -- Hologic, Inc. has announced the Company's financial results for the fiscal third quarter ended June 25, 2016 . GAAP diluted...Read more
2016 05 Jul
Hologic, Inc. has announced that it has notified holders of the 2.00% Convertible Exchange Senior Notes due 2037 (CUSIP No. 436440 AB7) issued November 23, 2010, and Wilmington Trust Company, the trustee, paying agent and conversion agent for the notes, that holders are eligible to convert the notes. This conversion right is subject to the terms of...Read more
2016 01 Jul
Hologic, Inc. has announced that the Company plans to release its financial results for the third quarter of fiscal 2016 on Wednesday, July 27, 2016 , after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time . Interested participants may listen to the call by dialing...Read more
2016 20 Jun
New Diagnostic Test for the Detection of the Zika Virus Now Available for Use on Fully Automated Panther System Hologic, Inc. has announced that the U.S. Food and Drug Administration (FDA) granted emergency use authorization for the company's new, diagnostic assay for Zika virus infection. The Aptima® Zika Virus assay is a molecular diagnostic...Read more
2016 15 Jun
Mammography customers highlight Hologic's high image quality, strong customer support, and market-leading product innovations Hologic has announced that the Company received top marks from U.S. mammography providers in a new independent report from KLAS Research, with 96 percent of customers reporting that Hologic systems are worth the investment....Read more
2016 02 Jun
Award-winning performer and breast cancer survivor to educate women about early detection and the Genius™ 3D MAMMOGRAPHY™ exam Hologic, Inc. has announced that nine-time Grammy award-winning singer, songwriter and breast cancer survivor Sheryl Crow will serve as national spokesperson to educate women about a more accurate mammogram, the Genius™...Read more
2016 11 May
Company Also Will Feature Full Range of Women's Health Topics at 2016 American College of Obstetricians and Gynecologists (ACOG) Annual Clinical and Scientific Meeting Hologic, Inc. has announced that the MyoSure® suite of gynecologic surgical products is expanding to include the MyoSure REACH device. The MyoSure REACH device confronts the...Read more
2016 04 May
Hologic, Inc. has announced that the Company will present at these upcoming investor conferences: The Bank of America Merrill Lynch 2016 Health Care Conference in Las Vegas, NV on Tuesday, May 10 at 11:20 am Pacific Time (PT) /2:20 pm Eastern Time (ET). The UBS Global Healthcare Conference in New York, NY on Tuesday, May 24 at 1Read more
2016 03 May
Co-testing with Pap+HPV Together™ results in significantly fewer false-negative results than either test used alone 1 A new cervical cancer screening study demonstrates that Pap+HPV Together™ (co-testing) remains the most effective strategy for detecting high-grade cervical lesions 1,2, Hologic, Inc. has announced. The study, published...Read more
2016 02 May
New Data Suggests Nearly Half of Women Neglect to Take Action Against Osteoporosis While nearly three-quarters of Americans (71%) are aware of the effects that osteoporosis can have on their health, only about half report taking any steps to prevent it, 1 according to the results of a new survey has announced by Hologic. To mark the start...Read more
2016 28 Apr
- GAAP Diluted EPS of $0.24 Increases 41.2%, Non-GAAP Diluted EPS of $0.47 Increases 14.6% - - Revenue of $693.3 Million Grows 5.8% on a Reported Basis, 6.3% in Constant Currency - - Company Redeploys $460.2 Million of Capital to Reduce Convertible Debt, and Repurchase Shares - Hologic, Inc. has announced the Company's financial results for...Read more
2016 28 Apr
Breast tomosynthesis exams, combined with conventional mammography, can help reduce recall rates, and increase invasive cancer detection in women with both dense and non-dense breasts, according to research published in the Journal of the American Medical Association. These key benefits could lower the costs associated with needless follow-up...Read more
2016 27 Apr
Reducing Recall Rate for Breast Cancer Screening Stands to Decrease Healthcare Costs and Increase Quality of Care for Women Hologic, Inc. has announced that study results published today in a research letter in JAMA conclude that breast tomosynthesis (Hologic's Genius™ 3D MAMMOGRAPHY™) exams reduce recall rates, and increase invasive cancer detection...Read more
2016 21 Apr
New System Pairs 360-Degree Breast Access with Exceptional 2D/3D™ Biopsy Imaging Hologic, Inc. has announced the U.S. Food and Drug Administration (FDA) clearance and commercial launch of the Affirm™ prone biopsy system, the first dedicated prone biopsy system to offer both 2D and 3D™ imaging-guided breast biopsies. "At Hologic, we challenge...Read more
2016 02 Apr
Hologic, Inc. has announced that it has notified holders of the 2.00% Convertible Exchange Senior Notes due 2037 (CUSIP No. 436440 AB7) issued November 23, 2010 , and Wilmington Trust Company, the trustee, paying agent and conversion agent for the notes, that holders are eligible to convert the notes. This conversion right is subject to the terms...Read more
2016 01 Apr
Hologic, Inc. has announced that the Company plans to release its financial results for the second quarter of fiscal 2016 on Wednesday, April 27, 2016, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time. Interested participants may listen to the call by dialing 888-455-2271...Read more
2016 04 Mar
The CE-Marked Affirm™ Prone Biopsy System Provides Enhanced 2D/3D™ Biopsy Imaging and Faster, Easier Access to the Breast [i] Hologic, Inc. has announced the European launch of the CE-marked Affirm™ prone biopsy system — the first dedicated prone biopsy system capable of both 2D and 3D™ imaging-guided breast biopsies. The new product is...Read more
2016 02 Mar
Hologic, Inc. (Nasdaq: HOLX) has announced that Christopher J. Coughlin has joined the Company's Board of Directors. Mr. Coughlin was elected to the Board at the Company's 2016 Annual Meeting of Stockholders, along with nine existing Directors who were re-elected. Mr. Coughlin, who in December was named "Director of the Year" by the National Association...Read more
2016 19 Feb
Hologic Inc. has announced that a new longitudinal study published online in advance of print in JAMA Oncology reports that women screened for breast cancer over multiple years using Hologic's Genius 3D MAMMOGRAPHY™ exams benefited from a significant drop in costly and stressful recalls. 1 The findings published in JAMA Oncology provide longitudinal...Read more
2016 15 Feb
Several locations have started high volume screening with Hologic 3D Mammography™ in Europe. A large scale adoption is ongoing in the USA with some locations past their third screening round with Hologic 3D Mammography. Results from the use of this technology in screening are concordant and very positive around an increase in invasive cancer detection...Read more
2016 15 Feb
Hologic is offering a series of 90-minute educational sessions for radiologists throughout the ECR Congress. Prior to the hands-on, a brief lecture will be provided by a radiologist pioneer in the clinical use of 3D Mammography™, who will present an overview of the technology and reading principles of tomosynthesis. This program is intended for radiologists...Read more
2016 15 Feb
Hologic is offering a series of 45-minute educational sessions for radiologists. A brief lecture will provide an overview of the clinical experiences with vacuum breast biopsies guided by 3D Imaging, prior to a demonstration of a phantom procedure using live imaging supervised by radiation protection services. This program is intended for radiologists...Read more
2016 15 Feb
Hologic is offering a series of 45-minutes educational sessions for radiologists. A brief lecture will provide an overview of the clinical experiences of imaging and new quantification applications of DXA. This program is intended for radiologists interested in learning more about new application based on the Hologic DXA technology. Date...Read more
2016 03 Feb
Hologic, Inc. has announced that the Company will present at these upcoming investor conferences: The LEERINK Partners 5 th Annual Global Healthcare Conference in New York, NY on Wednesday, February 10 at 3:05 pm Eastern Time (ET). The RBC Capital Markets 2016 Global Healthcare Conference in New York, NY on Tuesday, FebrRead more
2016 05 Jan
Hologic, Inc. has announced that it has notified holders of the 2.00% Convertible Exchange Senior Notes due 2037 (CUSIP No. 436440 AB7) issued November 23, 2010, and Wilmington Trust Company, the trustee, paying agent and conversion agent for the notes, that holders are eligible to convert the notes. This conversion right is subject to the terms of...Read more
2016 04 Jan
Hologic, Inc. has announced that the Company plans to release its financial results for the first quarter of fiscal 2016 on Wednesday, January 27, 2016 , after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time . Interested participants may listen to the call by dialing...Read more
2015 22 Dec
Hologic, Inc. has expressed support for new federal measures that preserve access to mammography for breast cancer screening and increase incentives for biomedical research and development. These measures were recently passed with bipartisan Congressional support and signed into law by the President. Essential components of the Protect Access to...Read more
2015 21 Dec
Hologic, Inc. has announced that the Company will present at the 34th Annual J.P. Morgan Healthcare Conference in San Francisco on January 12, 2016 at 2 p.m. Pacific Time . The presentation will be webcast live and may be accessed through a link on the investors section of Hologic's website at http://investors.hologic.com . The webcast will...Read more
2015 16 Dec
-- The CE-marked Aptima® Mycoplasma genitalium Assay on the Panther® System Identifies a Prevalent, Often Misdiagnosed Sexually Transmitted Infection -- Hologic, Inc. has announced the European launch of the CE-marked Aptima Mycoplasma genitalium assay, adding to the growing menu of molecular tests available on the fully automated Panther system....Read more